PMSC-NIFEDIPINE ER

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 91041026521e41ee
Drug Approval Canada Name: PMSC-NIFEDIPINE ER
Product Name: PMSC-NIFEDIPINE ER
Status: Marketed
Status Date: 2023-03-21
Original Market Date: 2023-03-21
Din: 02533332
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:28.08
Atc Original: C08CA05 NIFEDIPINE
Atc Name: c 08 ca 05
Aig Number: 0115253004
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

NIFEDIPINE

30 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

91041026521e41ee

Type

Standard